Cargando…
Pingyangmycin and Bleomycin Share the Same Cytotoxicity Pathway
Pingyangmycin is an anticancer drug known as bleomycin A5 (A5), discovered in the Pingyang County of Zhejiang Province of China. Bleomycin (BLM) is a mixture of mainly two compounds (A2 and B2), which is on the World Health Organization’s list of essential medicines. Both BLM and A5 are hydrophilic...
Autores principales: | He, Yanli, Lan, Ying, Liu, Yong, Yu, Haibo, Han, Zhangrun, Li, Xiulian, Zhang, Lijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274306/ https://www.ncbi.nlm.nih.gov/pubmed/27376254 http://dx.doi.org/10.3390/molecules21070862 |
Ejemplares similares
-
Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues
por: Lan, Ying, et al.
Publicado: (2020) -
Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system
por: Zhao, Qianying, et al.
Publicado: (2017) -
Sclerotherapy for the recurrent granulomatous epulis with pingyangmycin
por: Cai, Yu, et al.
Publicado: (2017) -
Proapoptotic effect and the mechanism of action of pingyangmycin on cavernous hemangiomas
por: HUANG, YIDENG, et al.
Publicado: (2014) -
The effect of hydroxycamptothecin and pingyangmycin on human squamous cell carcinoma of the tongue
por: CHEN, PENG, et al.
Publicado: (2013)